Teripitin Tablet 20 mg (Teneligliptin Hydrobromide Hydrate)

Adult dose

The recommended dose for this medication in monotherapy or combination therapy is 20 mg once daily. It can be taken regardless of meals. When used in combination with sulfonylureas, a reduction in sulfonylurea dosage may be considered. No dose adjustment is necessary for patients with renal impairment or mild to moderate hepatic impairment.

This medication is used for treating diabetes and helps in blood sugar control. Do not use this medication if you have an allergic reaction or hypersensitivity to any of its ingredients. It is not suitable for patients with type 1 diabetes or those in diabetic ketoacidosis or coma, and should not be used when insulin treatment is necessary. Caution is required for patients with severe infections, those undergoing surgery, or patients with serious injuries. Patients with severely impaired liver function or heart failure should use this medication cautiously, and it is especially not recommended for patients with severe heart failure. Taking this medication with sulfonylureas or insulin may increase the risk of hypoglycemia, so caution is warranted. Patients with conditions that increase the risk of hypoglycemia such as pituitary or adrenal insufficiency, malnutrition, irregular meals, excessive exercise, or excessive alcohol intake should take this medication carefully. Patients with a history of abdominal surgery or bowel obstruction, cardiac arrhythmias, or those at risk for QT interval prolongation due to hypokalemia should also use caution. Acute pancreatitis symptoms may occur, so if persistent abdominal pain or vomiting arises, immediate consultation with medical personnel is necessary. Symptoms of hypoglycemia may occur, so if symptoms appear, immediate action such as consuming sugar is needed. Side effects such as constipation, abdominal pain, liver function abnormalities, interstitial pneumonia, rashes, etc., may occur, so report any unusual symptoms to a healthcare provider. This medication lacks safety information for pregnant or breastfeeding women, so careful use is advised, and safety and efficacy have not been established in children. Elderly patients may experience reduced body function, so monitoring their condition during administration is necessary. In cases of overdose, gastrointestinal decontamination should be performed and monitoring through electrocardiogram and appropriate treatment should be initiated. Interactions with other medications may occur, especially with insulin, sulfonylureas, certain antifungals, and drugs for cardiac arrhythmia, necessitating caution when used together. During the course of taking this medication, understanding the symptoms of hypoglycemia and how to respond is crucial, and immediate consultation with healthcare personnel is required for any abnormal symptoms.

Serious side effects

Hives, severe swelling (edema), cold sweat, pallor, severe allergic reaction, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, liver dysfunction (symptoms related to jaundice), sudden and very severe headache, thunderclap headache, seizures, confusion of consciousness, vision abnormalities, paralysis, significantly reduced urine output

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• abdominal bloating
• abdominal discomfort
• nausea
• abdominal pain
• flatulence
• stomatitis
• gastric polyps

Store this medication in a tightly sealed container to protect it from air, and it is best to keep it at room temperature between 1 degree and 30 degrees. This helps to maintain the medication's effectiveness for a longer period.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle